Riverpharma Ltd
12959904
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
Secil Geyik
director · Since 19/10/2020
Turkish
CompanyRankvs 22540+ SIC 52290 peers64
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/07/2025
Net Worth
£12k
Balance sheet strength
Cash
£8k
Cash in the bank
Net Current Assets
£11k
Working capital
Current Assets
£21k
Current Liabilities
£11k
Fixed Assets
£2k
Debtors
£14k
Profit After Tax
£16k
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 2.02 | -£8k |
| 2024 | 4.93 | — |
Derived from filed accounts. Not audited figures.